Payment overview · 2025
General Payments
$16.27
1 reported records · 1 companies
Healthcare provider profile · identity verified
Steven C. Ingalsbe, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · EL PASO, IL · NPI 1962428128
Verified facts
What the public records show
CMS Open Payments records show Steven C. Ingalsbe, M.D. received $16.27 in general payments during 2025 across 1 reported records.
Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Fiasp as an associated drug or biological on 15 records involving 15 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Fiasp by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 32 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $16.27 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $16.27 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $16.27 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 32 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Fiasp open payments reported associated product |
CMS Open Payments — General Payments 15 supporting records · 15 recipient NPIs · example record 1188262936 |
Fiasp · 2024 Exact normalized brand match · 1 Part D row |
28 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
32 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1300 | 218 |
| Furosemide | Furosemide | 1164 | 197 |
| Eliquis | Apixaban | 1138 | 120 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1063 | 143 |
| Potassium Chloride | Potassium Chloride | 962 | 139 |
| Amlodipine Besylate | Amlodipine Besylate | 844 | 140 |
| Gabapentin | Gabapentin | 773 | 114 |
| Sertraline Hcl | Sertraline Hcl | 766 | 113 |
| Metoprolol Succinate | Metoprolol Succinate | 693 | 104 |
| Pantoprazole Sodium | Pantoprazole Sodium | 688 | 104 |
| Lisinopril | Lisinopril | 687 | 94 |
| Losartan Potassium | Losartan Potassium | 550 | 82 |
| Tamsulosin Hcl | Tamsulosin Hcl | 539 | 101 |
| Metoprolol Tartrate | Metoprolol Tartrate | 534 | 92 |
| Clopidogrel | Clopidogrel Bisulfate | 516 | 67 |
| Donepezil Hcl | Donepezil Hcl | 504 | 77 |
| Metformin Hcl | Metformin Hcl | 471 | 59 |
| Mirtazapine | Mirtazapine | 383 | 62 |
| Myrbetriq | Mirabegron | 346 | 20 |
| Carvedilol | Carvedilol | 341 | 59 |
| Trazodone Hcl | Trazodone Hcl | 315 | 58 |
| Escitalopram Oxalate | Escitalopram Oxalate | 286 | 49 |
| Memantine Hcl | Memantine Hcl | 284 | 46 |
| Spironolactone | Spironolactone | 262 | 49 |
| Buspirone Hcl | Buspirone Hcl | 259 | 43 |
| Quetiapine Fumarate | Quetiapine Fumarate | 258 | 56 |
| Warfarin Sodium | Warfarin Sodium | 257 | 20 |
| Jardiance | Empagliflozin | 253 | 22 |
| Allopurinol | Allopurinol | 243 | 36 |
| Omeprazole | Omeprazole | 240 | 63 |
| Duloxetine Hcl | Duloxetine Hcl | 223 | 42 |
| Levetiracetam | Levetiracetam | 216 | 31 |
| Famotidine | Famotidine | 215 | 39 |
| Montelukast Sodium | Montelukast Sodium | 214 | 33 |
| Xarelto | Rivaroxaban | 211 | 20 |
| Pravastatin Sodium | Pravastatin Sodium | 210 | 27 |
| Fluoxetine Hcl | Fluoxetine Hcl | 207 | 22 |
| Prednisone | Prednisone | 198 | 49 |
| Simvastatin | Simvastatin | 196 | 30 |
| Baclofen | Baclofen | 194 | 27 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 187 | 26 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 178 | 56 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 176 | 33 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 173 | 34 |
| Latanoprost | Latanoprost | 162 | 34 |
| Fluticasone Propionate | Fluticasone Propionate | 160 | 54 |
| Hydrochlorothiazide | Hydrochlorothiazide | 156 | 29 |
| Tramadol Hcl | Tramadol Hcl | 156 | 45 |
| Paroxetine Hcl | Paroxetine Hcl | 140 | 19 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 136 | 28 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 133 | 19 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 127 | 18 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 127 | 14 |
| Tradjenta | Linagliptin | 125 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 123 | 25 |
| Glipizide | Glipizide | 116 | 17 |
| Hydralazine Hcl | Hydralazine Hcl | 112 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 110 | 68 |
| Lamotrigine | Lamotrigine | 104 | 16 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 98 | 15 |
| Torsemide | Torsemide | 97 | 17 |
| Januvia | Sitagliptin Phosphate | 96 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 93 | 13 |
| Lorazepam | Lorazepam | 92 | 26 |
| Aripiprazole | Aripiprazole | 87 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 87 | 29 |
| Divalproex Sodium | Divalproex Sodium | 87 | 19 |
| Cephalexin | Cephalexin | 86 | 52 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 85 | 40 |
| Ezetimibe | Ezetimibe | 84 | 14 |
| Bupropion Xl | Bupropion Hcl | 80 | 11 |
| Diltiazem Hcl | Diltiazem Hcl | 80 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 80 | 55 |
| Oxybutynin Chloride | Oxybutynin Chloride | 80 | 16 |
| Alprazolam | Alprazolam | 78 | 23 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 76 | 40 |
| Alendronate Sodium | Alendronate Sodium | 75 | 14 |
| Metolazone | Metolazone | 75 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 74 | 24 |
| Celecoxib | Celecoxib | 73 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 71 | 42 |
| Metformin Hcl Er | Metformin Hcl | 71 | 13 |
| Digoxin | Digoxin | 69 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 69 | 16 |
| Sucralfate | Sucralfate | 69 | 16 |
| Gemtesa | Vibegron | 68 | suppressed |
| Finasteride | Finasteride | 67 | 23 |
| Amiodarone Hcl | Amiodarone Hcl | 66 | 12 |
| Atenolol | Atenolol | 64 | 13 |
| Entresto | Sacubitril/Valsartan | 64 | suppressed |
| Chlorthalidone | Chlorthalidone | 62 | suppressed |
| Clonazepam | Clonazepam | 61 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 60 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 60 | 13 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 59 | 38 |
| Pioglitazone Hcl | Pioglitazone Hcl | 57 | suppressed |
| Nystatin | Nystatin | 56 | 34 |
| Clonidine Hcl | Clonidine Hcl | 55 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 54 | 52 |
| Ipratropium Bromide | Ipratropium Bromide | 53 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 53 | 13 |
| Olanzapine | Olanzapine | 52 | 17 |
| Farxiga | Dapagliflozin Propanediol | 49 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 49 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 48 | 31 |
| Glipizide Er | Glipizide | 48 | suppressed |
| Nystop | Nystatin | 48 | 21 |
| Albuterol Sulfate | Albuterol Sulfate | 47 | 31 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 47 | 15 |
| Doxazosin Mesylate | Doxazosin Mesylate | 47 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 46 | suppressed |
| Folic Acid | Folic Acid | 46 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 46 | suppressed |
| Azithromycin | Azithromycin | 45 | 24 |
| Methenamine Hippurate | Methenamine Hippurate | 45 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 43 | 11 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 43 | 24 |
| Solifenacin Succinate | Solifenacin Succinate | 43 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 42 | suppressed |
| Pregabalin | Pregabalin | 42 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 41 | suppressed |
| Budesonide | Budesonide | 40 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 40 | suppressed |
| Carbamazepine | Carbamazepine | 40 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 40 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 39 | suppressed |
| Ondansetron Odt | Ondansetron | 39 | 22 |
| Risperidone | Risperidone | 39 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 38 | 27 |
| Fentanyl | Fentanyl | 38 | suppressed |
| Levofloxacin | Levofloxacin | 38 | 24 |
| Meloxicam | Meloxicam | 38 | suppressed |
| Valsartan | Valsartan | 38 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 37 | suppressed |
| Calcitriol | Calcitriol | 37 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 37 | suppressed |
| Methotrexate | Methotrexate Sodium | 36 | suppressed |
| Fenofibrate | Fenofibrate | 35 | suppressed |
| Fluconazole | Fluconazole | 35 | 20 |
| Hydrocortisone | Hydrocortisone | 35 | 15 |
| Hydroxyurea | Hydroxyurea | 35 | suppressed |
| Nifedipine Er | Nifedipine | 35 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 34 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 34 | 12 |
| Verapamil Er | Verapamil Hcl | 34 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 33 | 22 |
| Kapspargo Sprinkle | Metoprolol Succinate | 33 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 33 | suppressed |
| Glimepiride | Glimepiride | 32 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 32 | suppressed |
| Ozempic | Semaglutide | 32 | suppressed |
| Primidone | Primidone | 32 | suppressed |
| Tobradex | Tobramycin/Dexamethasone | 32 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 32 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 31 | suppressed |
| Amoxicillin | Amoxicillin | 31 | 23 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 31 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 31 | suppressed |
| Lactulose | Lactulose | 31 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 31 | 17 |
| Breo Ellipta | Fluticasone/Vilanterol | 30 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 30 | 19 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 29 | suppressed |
| Bumetanide | Bumetanide | 28 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 28 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 28 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 28 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 28 | suppressed |
| Novolog | Insulin Aspart | 28 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 28 | 12 |
| Ketoconazole | Ketoconazole | 27 | 11 |
| Metoclopramide Hcl | Metoclopramide Hcl | 27 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 27 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 27 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 27 | suppressed |
| Brilinta | Ticagrelor | 26 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 26 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 25 | suppressed |
| Lovastatin | Lovastatin | 25 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 25 | 12 |
| Admelog | Insulin Lispro | 24 | suppressed |
| Jentadueto Xr | Linagliptin/Metformin Hcl | 24 | suppressed |
| Novolog Flexpen | Insulin Aspart | 24 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 24 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 23 | suppressed |
| Mesalamine Dr | Mesalamine | 23 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 23 | suppressed |
| Timolol Maleate | Timolol Maleate | 23 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 22 | 15 |
| Paxlovid | Nirmatrelvir/Ritonavir | 22 | 22 |
| Cholestyramine | Cholestyramine (With Sugar) | 21 | suppressed |
| Mesalamine | Mesalamine | 21 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 20 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 20 | suppressed |
| Lansoprazole | Lansoprazole | 20 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 20 | suppressed |
| Minoxidil | Minoxidil | 20 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 20 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 20 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 19 | suppressed |
| Linzess | Linaclotide | 19 | suppressed |
| Nitroglycerin | Nitroglycerin | 19 | 17 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 18 | suppressed |
| Metronidazole | Metronidazole | 18 | 13 |
| Sotalol | Sotalol Hcl | 18 | suppressed |
| Anastrozole | Anastrozole | 17 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 17 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 17 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 17 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 17 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 17 | suppressed |
| Nyamyc | Nystatin | 17 | 13 |
| Trulicity | Dulaglutide | 17 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 16 | suppressed |
| Insulin Lispro | Insulin Lispro | 16 | suppressed |
| Lacosamide | Lacosamide | 16 | suppressed |
| Topiramate | Topiramate | 16 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 16 | suppressed |
| Calcium Acetate | Calcium Acetate | 15 | suppressed |
| Erythromycin | Erythromycin Base | 15 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 15 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 15 | 12 |
| Admelog Solostar | Insulin Lispro | 14 | suppressed |
| Balsalazide Disodium | Balsalazide Disodium | 14 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 14 | suppressed |
| Cyclosporine | Cyclosporine | 14 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 14 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 14 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 14 | suppressed |
| Mirabegron Er | Mirabegron | 14 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 14 | suppressed |
| Ranolazine Er | Ranolazine | 14 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 14 | suppressed |
| Acetazolamide | Acetazolamide | 13 | suppressed |
| Azathioprine | Azathioprine | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 13 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 13 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 13 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 13 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Acebutolol Hcl | Acebutolol Hcl | 12 | suppressed |
| Avonex (4 Pack) | Interferon Beta-1a | 12 | suppressed |
| Humalog | Insulin Lispro | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 12 | suppressed |
| Motegrity | Prucalopride Succinate | 12 | suppressed |
| Phenytoin | Phenytoin | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Silodosin | Silodosin | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 12 | suppressed |
| Aimovig Autoinjector | Erenumab-Aooe | 11 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 11 | suppressed |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 11 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 11 | suppressed |
| Dutasteride | Dutasteride | 11 | suppressed |
| Ertapenem | Ertapenem Sodium | 11 | suppressed |
| Letrozole | Letrozole | 11 | suppressed |
| Levetiracetam Er | Levetiracetam | 11 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Pentoxifylline | Pentoxifylline | 11 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 11 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $16.27 · 1 records | Novo Nordisk Inc | Ozempic | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error